Communication Between Physicians and Patients with Ulcerative Colitis: Reflections and Insights from a Qualitative Study of In-Office Patient–Physician Visits
暂无分享,去创建一个
[1] J. Telliez,et al. JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines. , 2016, American journal of physiology. Gastrointestinal and liver physiology.
[2] D. Rubin,et al. Using a Treat-to-Target Management Strategy to Improve the Doctor–Patient Relationship in Inflammatory Bowel Disease , 2015, The American Journal of Gastroenterology.
[3] Yoon Tae Jeen,et al. Current and Emerging Biologics for Ulcerative Colitis , 2015, Gut and liver.
[4] A. Lyra,et al. Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis. , 2014, World journal of gastroenterology.
[5] P. Rutgeerts,et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. , 2013, The New England journal of medicine.
[6] S. Vermeire,et al. Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Current management , 2012 .
[7] Carla K. Miller,et al. Shared decision making and other variables as correlates of satisfaction with health care decisions in a United States national survey. , 2012, Patient education and counseling.
[8] S. Hahn,et al. Effect of patient-centered communication training on discussion and detection of nonadherence in glaucoma. , 2010, Ophthalmology.
[9] A. Kornbluth,et al. Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee , 2010, The American Journal of Gastroenterology.
[10] S. Hahn,et al. Doctor-patient communication in glaucoma care: analysis of videotaped encounters in community-based office practice. , 2009, Ophthalmology.
[11] E. Kuipers,et al. Patient’s Perspectives Important for Early Anti-Tumor Necrosis Factor Treatment in Inflammatory Bowel Disease , 2009, Digestion.
[12] Philip A. Bain,et al. In-office Discussions of Migraine: Results from the American Migraine Communication Study , 2008, Journal of General Internal Medicine.
[13] V. Vogel,et al. Oncologist-patient discussion of adjuvant hormonal therapy in breast cancer: results of a linguistic study focusing on adherence and persistence to therapy. , 2007, The journal of supportive oncology.
[14] S. Travis,et al. Guidelines for the management of inflammatory bowel disease in adults , 2004, Gut.
[15] G. Triadafilopoulos,et al. Communicating with patients with inflammatory bowel disease. , 2004, Inflammatory bowel diseases.
[16] J. Gumperz. On interactional sociolinguistic method , 1999 .
[17] S. Sarangi,et al. Talk, work, and institutional order : discourse in medical, mediation, and management settings , 1999 .
[18] C. FordAlexander,et al. ULCERATIVE colitis. , 1997, Journal of the American Medical Association.
[19] David Cella,et al. Communicating about chemotherapy-induced anemia. , 2007, The journal of supportive oncology.
[20] H. Hamilton. Symptoms and signs in particular: the influence of the medical concern on the shape of physician-patient talk. , 2004, Communication & medicine.
[21] G PLACITELLI,et al. [Ulcerative colitis]. , 1958, La Riforma medica.